Evidence map›Paper›PMID 24014133›Full record

ArticleInternational urology and nephrology2014

The effects of preoperative immunosuppressive therapy on ischemia and reperfusion (I/R) injury in healthy rats.

Selcuk Kilinc, Sedat Tan, Efsun Hatice Kolatan, Dane Ruscuklu, Esra Satici, Mehmet Kemiksiz, Lutfi Dalkilic, Umut Eren Erdogdu, Cezmi Karaca

Abstract read
PubMed Publisher
In one paragraph

Article in International urology and nephrology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 90% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Selcuk Kilincİzmir Tepecik Training and Research Hospital Transplant Department, Izmir, Turkey.
Sedat Tan
Efsun Hatice Kolatan
Dane Ruscuklu
Esra Satici
Mehmet Kemiksiz
Lutfi Dalkilic
Umut Eren Erdogdu
Cezmi Karaca
Izmir Tepecik Eğitim ve Araştırma Hastanesi · TRDokuz Eylül University · TRGeneral Directorate of Highways · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeWarm-ischemia-induced injuries might be encountered during renal transplants from cadavers and healthy donors. Toll-like receptors (TLR) in ischemia-reperfusion (I/R) injury are one of the indicators of intracellular injury pathways. The intensity of ischemic injury is directly proportionate to high TLR levels. To minimize the I/R injury, we investigated TLR2 and TLR4 levels on rats, which were pretreated with tacrolimus (FK506) before I/R.

methodsEight Wistar albino rats in the study group were administered .01 mg/kg intramuscular tacrolimus. Administration to the study group was performed 24 and 1 h before warm ischemia. Eight rats in the control group were injected with 0.1 c.c. of distilled water. Blood samples were collected from the tail veins of all the rats on the first, second and third days. Expression levels of TLR2 and TLR4 genes were analyzed using the polymerase chain reaction method, to determine any significant difference between the control and study groups on the days when blood was taken.

resultsTLR2 (p = 0.045) and TLR4 (p = 0.022) levels in the study group were found to be statistically, and significantly, lower than those in the control group, on the second day following warm-ischemia- and reperfusion-induced injury.

conclusionsAdministration of immunosuppressive drugs to healthy donor rats led to a statistically significant reduction in the expression levels of TLR2 and TLR4 in the early period. In light of the data obtained by this study, we hypothesize that a preoperative therapy on donors might have a role in preventing I/R injury.

Indexed as

AnimalsGene ExpressionImmunosuppressive AgentsKidney TransplantationPreoperative CareRatsRats, WistarReperfusion InjuryRNATacrolimusToll-Like Receptor 2Toll-Like Receptor 4Immunosuppressive AgentsRNATacrolimusToll-Like Receptor 2Toll-Like Receptor 4

Identifiers

PMID24014133
OpenAlexW2016192973

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.